Analysis of intrahepatic HBVDNA in serologic HBV markers-negative or HBsAg-negative patients with chronic hepatitis

Abstract

To explore HBV infection status in a group of serologic HBV markers-negative or HBsAg-negative patients with chronic hepatitis, in situ hybridization to hepatccellular HBVDNA was carried out in combination with detection of HBsAg and HBcAg in the liver tissues. It was found that prevalence of intrahepatic HBVDNA, HBsAg and HBcAg was 43 %, 39 % and 17 % respectively, and 15 out of 23 cases studied were sure to bear one or more positive marker (s) of intrahepatic HBVDNA, HBsAg and HBcAg. These findings suggest that more than half of the patients with chronic hepatitis were still undergoing HBV infection, despite serologic HBV markers or HBsAg negative. Furthermore, we found that hepatocytes containing HBV-DNA or surface or core antigen were often close to hepatic necrosis foci, indicating that HBV replication and its antigen(s) expression in hepatocytes could account for chronic, active and necrotic inflammation occurring in the liver of the patients mentioned above.

Keywords

chronic hepatitis / HBV markers / HBVDNA / in situ hybridization / pathogenesis

References

[1] BoninoF, et al.. Hepatitis B virus DNA in the sera of HEsAg carriers: a marker of active hepatitis B virus replication in the liver. Hepatology, 1981, 1: 386-386

[2] LiawYF, et al.. Determinants for hepatitis B e antigen clearance in chronic type B hepatitis. Liver, 1984, 4: 301-301

[3] HadziyannisSJ, et al.. Analysis of liver disease, nuclear HBcAg, viral replication and hepatitis B virus DNA in liver and serum of HEeAg versus anti-HBe positive carriers of hepatitis B virus. Hepatology, 1983, 3: 656-656

[4] NicolaosC, et al.. Significance of IgM antibody to hepatitis B core antigen in a Greek population with chronic hepatitis B virus infection. Liver, 1986, 6: 275-275

[5] KrogsgaardK, et al.. Hepatitis B virus DNA in serum. Applied molecular biology in the evaluation of hepatitis B virus infection. Liver, 1988, 8: 237-237

[6] International Group. Acute and chronic hepatitis revised. Lancet, 1977, 2: 914-914

[7] ZhangYY, et al.. Morphology, distribution and its significance of intrahepatic HBVDNA in liver disease: a study by in situ hybridization. J Tongji Med Univ, 1989, 9: 204-204

[8] NegroF, et al.. Detection of HBVDNA by in situ hybridization using a biotinlabeled probe. J Med Virol, 1935, 15: 373-373

[9] HerrmannG, HubnerK. In situ hybridization with HBVDNA as a sensitive method for diagnosis of hepatitis B infection in persistent acute hepatitis. Hepatogastroenterclogy, 1987, 34: 148-148

[10] RijntjesPJM, et al.. Hepatitis B virus DNA detected in formalin-fixed liver specimens and its relation to serologic markers and histopathologic features in chronic liver disease. AJP, 1985, 120: 411-411

[11] KanekoS, et al.. Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proc Natl Acad Sci USA, 1989, 86: 312-312

[12] FaulP, et al.. Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees. J Infect Dis, 1989, 160: 37-37

[13] HsuHC, et al.. Correlation of hepatocyte HBsAg expression with virus replication and liver pathology. Hepatology, 1985, 8: 749-749

[14] RamalhoF, et al.. Serum markers of hepatitis B virus replication, liver histology and intrahepatic expression of hepatitis B core antigen. Hepatology, 1988, 8: 1-1

[15] MichitakaK, et al.. Change of hepatitis B virus DNA distribution associated with the progression of chronic hepatitis. Liver, 1988, 8: 247-247